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We used a 2D-electrophoresis (2-DE) proteomic approach to identify novel
biomarkers in node-negative breast cancers. This retrospective study focused on a
population of patients with ductal pN0M0 tumours. A subset of patients who
developed metastases and in whose tumours were found high levels of uPA and PAI-1
(metastatic relapse, MR: n=20) were compared to another subset in whom no
metastatic relapse occurred and whose tumours were found to have low levels of uPA
and PAI-1 (no relapse, NR: n=21). We used a 2-DE coupled with MS approach to
screen cytosol fractions using two pH-gradient scales, a broad scale (3.0-11.0) and a
narrower scale focussing in on a protein rich region (5.0-8.0). This study was
conducted on 41 cytosol specimens analyzed in duplicate on two platforms. The
differential analysis of more than 2,000 spots in 2-DE gels, obtained on the two
platforms, allowed the identification of 13 proteins which were confirmed by western
blotting. Two proteins, GPDA and FABP4 were down-regulated in the MR subset
whereas all the others were up-regulated. An in silico analysis revealed that GMPS
(GUAA), GAPDH (G3P), CFL1 (COF1) and FTL (FRIL), the most informative genes,
displayed a proliferation profile (high expression in basal-like, HER2+ and luminal B
molecular subtypes). Inversely, similar to FABP4, GPD1 [GPDA] displayed a high
expression in luminal A subtype, a profile characteristic of tumour suppressor genes.
Despite the small size of our cohort, the 2-DE analysis gave interesting results which
were confirmed by the in silico analysis showing that some of the corresponding
genes had a strong prognostic impact in breast cancer, mostly because of their link
with proliferation: GMPS, GAPDH, FTL and GPD1. A validation phase on a larger
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